Thrivent Financial for Lutherans
OGN icon

Thrivent Financial for Lutherans’s Organon & Co OGN Stock Holding History

Thrivent Financial for Lutherans’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Sell
172,441
-1,088
-0.6% -$13K ﹤0.01% 1435
2026
Q1 		$1.04M Sell
173,529
-5,110
-3% -$38.5K ﹤0.01% 1862
2025
Q4 		$1.28M Sell
178,639
-68,869
-28% -$544K ﹤0.01% 1768
2025
Q3 		$2.64M Sell
247,508
-57,962
-19% -$569K 0.01% 1167
2025
Q2 		$2.96M Buy
305,470
+116,303
+61% +$1.2M 0.01% 1102
2025
Q1 		$2.82M Sell
189,167
-9,898
-5% -$152K 0.01% 1078
2024
Q4 		$2.97M Sell
199,065
-3,125
-2% -$50.9K 0.01% 1179
2024
Q3 		$3.87M Sell
202,190
-11,300
-5% -$234K 0.01% 1048
2024
Q2 		$4.42M Sell
213,490
-51,086
-19% -$1.02M 0.01% 944
2024
Q1 		$4.97M Sell
264,576
-30,331
-10% -$521K 0.01% 896
2023
Q4 		$4.25M Buy
294,907
+284,164
+2,645% +$3.87M 0.01% 920
2023
Q3 		$186K Sell
10,743
-115
-1% -$2.4K ﹤0.01% 2388
2023
Q2 		$226K Sell
10,858
-61
-0.6% -$1.33K ﹤0.01% 2383
2023
Q1 		$257K Buy
10,919
+25
+0.2% +$671 ﹤0.01% 2325
2022
Q4 		$304K Buy
10,894
+46
+0.4% +$1.18K ﹤0.01% 2257
2022
Q3 		$254K Buy
10,848
+85
+0.8% +$2.57K ﹤0.01% 2277
2022
Q2 		$363K Buy
10,763
+40
+0.4% +$1.4K ﹤0.01% 2207
2022
Q1 		$375K Sell
10,723
-78
-0.7% -$2.67K ﹤0.01% 2295
2021
Q4 		$329K Sell
10,801
-74
-0.7% -$2.41K ﹤0.01% 2303
2021
Q3 		$357K Sell
10,875
-20,539
-65% -$657K ﹤0.01% 2276
2021
Q2 		$951K Buy
+31,414
New +$1.03M ﹤0.01% 1877

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Thrivent Financial for Lutherans's OGN Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its Organon & Co (OGN) stake by 0.63% in Q2 2026, selling an estimated $13K and leaving 172,441 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1435.

Thrivent Financial for Lutherans first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.97M in Q1 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Thrivent Financial for Lutherans held 172,441 shares of Organon & Co worth $2.33M as of Q2 2026.
  • Thrivent Financial for Lutherans sold 1,088 Organon & Co shares in Q2 2026, an estimated $13K.
  • Organon & Co made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1435 holding.
  • Thrivent Financial for Lutherans first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Thrivent Financial for Lutherans's Organon & Co position peaked at $4.97M in Q1 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.